Can Korea’s biosimilar project stay afloat?

Published: 2010-11-15 07:00:00

Updated: 2010-11-15 07:00:00

Influenced by US midterm elections results 2010 that the Republicans registered thumping victories in congressional elections and they have intensified their opposition to President Barack Obama’s healthcare reform of 2010, a number of the world’s leading generic markers are moving toward the dev...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK